Condition: Acute Kidney Injury · Adverse Drug Event · Sponsor: Rutgers, The State University of New Jersey
This study will evaluate the safety and effectiveness of melatonin for the prevention of antibiotic associated acute kidney injury in hospitalized patients.
This description comes directly from the study's public registry record.
Luigi Brunetti, PhD · 908-595-2645 · luigi.brunetti@rutgers.edu
Always discuss trial participation with your own doctor first.
| Robert Wood Johnson University Hospital | New Brunswick, New Jersey, United States | Recruiting |
| Robert Wood Johnson University Hospital Somerset | Somerville, New Jersey, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05084196